阿考替胺在中国上市了吗？好购买吗？

Acotiamide hydrochloride is an acetylcholinesterase inhibitor that inhibits acetylcholinesterase activity and reduces the decomposition of acetylcholine, thereby enhancing cholinergic neurotransmission. The drug promotes gastric emptying, improves gastric motility, and relieves postprandial fullness, epigastric fullness, and early satiety associated with functional dyspepsia. The domestic listing status, purchase difficulty and medical insurance coverage issues of acotiamide hydrochloride have attracted much attention. At present, the drug has not officially entered the Chinese market, and there are certain difficulties in obtaining it for patients.

Is acotiamide marketed in China?

Currently, it has not received marketing approval from the China National Medical Products Administration, and domestic patients cannot purchase the drug through formal channels.

Approval status

As of May 2025, acotiamide is still in the drug registration and approval stage in China. The Drug Evaluation Center of the State Food and Drug Administration has not yet announced the launch time of the drug. It has not been officially launched in the country and cannot be purchased directly in hospitals or pharmacies.

Clinical trial progress

Some domestic medical institutions are conducting clinical trials of acotiamide, and eligible patients can obtain the opportunity to use the drug by participating in clinical trials.

If domestic patients need to use the drug, they can currently only obtain it through special import or overseas purchase and other alternatives.

Is acotiamide easy to buy?

Since it has not been officially approved, acotiamide has limited domestic access channels and is difficult to purchase. Special attention needs to be paid to the reliability of the source of the drug.

Formal access methods

Patients can participate in domestic clinical trial projects to obtain acotiamide, apply for special import through hospitals, or purchase the drug directly from Japan and other listed countries. If you do not want to go abroad, you can also obtain acotiamide through domestic medical service institutions.

Purchase risk warning

Acotide sold through unknown channels on the Internet is risky and may be counterfeit and shoddy products. Patients are advised to choose purchasing channels carefully.

Complete drug import documents and inspection reports should be requested when purchasing to ensure drug quality.

Is acotiamide included in the national medical insurance?

Since it has not yet been launched in the country, acotiamide is not currently included in any medical insurance reimbursement list, and all medication costs must be paid by the patient in full.

Current status of medical insurance coverage

This drug is not included in the national medical insurance catalog and local supplementary medical insurance, and commercial insurance usually does not cover unapproved drugs. Patients need to pay for the drug at their own expense, and the economic pressure of long-term medication is relatively high.

Cost estimate

Referring to the Japanese market price, the monthly medication cost is about US$150-200. Special imports require additional tariffs and transportation fees.

In the absence of medical insurance reimbursement, patients need to fully consider the financial burden and explore possible cost reduction channels.